Mark McLaws' Professional Contact Details

Mobile Number (Verified)
Get Mobile Number
HQ
+861-919-468-3884
Location
North Carolina

Mark McLaws' Current Company Details

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commi...
At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share.Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem.Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials'​ manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done.Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
process r
d
continuous flow chemistry
biocatalysis
hydrogenation
cmc
api
small molecule
validation
hpapi
commercial manufacturing
cdmo
usfda inspected
development
late clinical phase
cmo
cgmp
ich q7a
r
kilo scale
pilot plant
pharmaceuticals
pharmaceutical manufacturing
medical

Mark McLaws' Work History and Education

Asymchem Group
Director of Process Chemistry
2015 - Present
Curia
Senior Research Scientist II
2007 - 2015 • 8 years

Others Named Mark McLaws

Director, Office of the CEO at Liberty Global

Frequently Asked Questions about Mark McLaws


What company does Mark McLaws work for?

Mark McLaws works for Asymchem Group.

What is Mark McLaws' role at Asymchem Group?

Mark McLaws' role at Asymchem Group is Vice President of Process Chemistry.

What is Mark McLaws' email address?

Mark McLaws' email address is m**@asymchem.com.

What is Mark McLaws' business email address?

Mark McLaws' business email address is m**@asymchem.com.

What is Mark McLaws' direct mobile number?

Mark McLaws' direct mobile number is (518) XXX-XXXX.

What is Mark McLaws' HQ phone number?

Mark McLaws' HQ phone number is +861-919-468-3884.

What industry does Mark McLaws work in?

Mark McLaws works in the Pharmaceuticals industry.

Who are Mark McLaws' colleagues?

Mark McLaws' colleagues are Ben Lam, Bryll Jenkins, Charles Chase, Chenlin Yang and more.

Colleagues at Asymchem Group

Senior Director
Associate Scientist
Vice President, Technical Business Development
Senior Researcher, Oligonucleotide Process Development
Vice General Manager

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download ExtensionRepresents linkedin prospector
Browse Apollo's Directories

"We love the interface, the experience, and most importantly… the results."

Erik Straub

Chief Marketing Officer, Kickfurther

"Using Apollo, we’ve solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects."

Michael Transon

CEO, Victorious

Ready to try it out?

Get started for free, then add your whole team. You can always talk to sales if you’re interested in advanced plans.